Pharmacological Treatment of Non-neurogenic Voiding Dysfunction

  • Alan J. Wein
Part of the Clinical Practice in Urology book series (PRACTICE UROLOG)


The lower urinary tract performs two functions: the storage and emptying of urine. The physiology of the cycle of micturition has been described by many qualified authors, each of whom has given his own particular concept of the neuroanatomy and neurophysiology of the smooth and striated muscular structures, the peripheral autonomic and somatic neural factors, and the spinal and supraspinal influences which are necessary for the normal micturition cycle. There are significant disagreements regarding the finer details of the relevant neuromorphology, neurophysiology and neuropharmacology. Perhaps the best example of this is the current controversy over the influence of the sympathetic nervous system on the physiology of micturition and the interrelationships, if any, of the parasympathetic and sympathetic influences on the smooth muscle of the urinary bladder and its outlet.


Stress Urinary Incontinence Bladder Outlet Obstruction Maximal Urethral Closure Pressure Bladder Smooth Muscle Proximal Urethra 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abel BJ, Jameson RM, Gibbon NOK, Krishnan KR (1974) The neuropathic urethra. Lancet II: 1229–1230CrossRefGoogle Scholar
  2. Abromowicz A (ed) (1978) Baclofen (Lioresal). Med Lett Drugs Ther 20: 43–44Google Scholar
  3. Allen TD (1977) The non-neurogenic neurogenic bladder. J Urol 117: 232–238PubMedGoogle Scholar
  4. Andersen JT (1976) Detrusor hyperreflexia in benign infravesical obstruction: a cystometric study. J Urol 115: 532–534PubMedGoogle Scholar
  5. Andersen JT, Walter S, Vejlsgaard R (1981) A clinical and bacteriological trial with DMSO in the treatment of severe detrusor hyperreflexia. Scand J Urol Nephrol [Suppl] 60: 63–65Google Scholar
  6. Anderson (1982) Evidence for a prostaglandin link in the purinergic activation of rabbit bladder smooth muscle. J Pharmacol Exp Ther 220: 347–352PubMedGoogle Scholar
  7. Andersson K-E, Hustad S, Sjogren C (1980) Contribution of prostaglandins to the adenosine triphosphate induced contraction of rabbit urinary bladder. Br J Pharmacol 70: 443–452PubMedGoogle Scholar
  8. Andersson K-E, Ek A, Hedlund H, Mattiasson A (1981) Effects of prazosin on isolated human urethra and in patients with lower motor neuron lesions. Invest Urol 19: 39–42PubMedGoogle Scholar
  9. Atkins FL, Nicolosi GL (1979) Alpha adrenergic blocking activity of prazosin. Biochem Pharmacol 28: 1233–1237PubMedCrossRefGoogle Scholar
  10. Awad SA, Downie JW, Kiruluta HG (1978) Alpha-adrenergic agents in urinary disorders of the proximal urethra. I. Sphincteric incontinence. Br J Urol 50: 332–335PubMedCrossRefGoogle Scholar
  11. BaldessariniRJ (1980) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 391–447Google Scholar
  12. Barrett DM (1981) The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol 126: 640–642PubMedGoogle Scholar
  13. Beisland HO, Fossberg E, Sander S (1981) On incompetent urethral closure mechanism: treatment with estriol and phenylpropanolamine. Scand J Urol Nephrol [Suppl] 60: 67–69Google Scholar
  14. Benson H, Epstein MD (1975) The placebo effect. JAMA 232: 1225–1226PubMedCrossRefGoogle Scholar
  15. Benson GS, Sarshik SA, Raezer DM, Wein AJ (1977) Bladder muscle contractility: comparative effects and mechanisms of action of atropine, propantheline, flavoxate, and imipramine. Urology 9: 31–35PubMedCrossRefGoogle Scholar
  16. Bigger JT, Giardina EGV, Perel JM, Kantor SJ, Glassman AH (1977) Cardiac anti-arrhythmic effect of imipramine hydrochloride. N Engl J Med 296: 206–208PubMedCrossRefGoogle Scholar
  17. Birkasova M, Birkas, O, Flynn MJ, Cort JH (1978) Desmopressin in the management of nocturnal enuresis in children: a double-blind study. Pediatrics 62: 970–974PubMedGoogle Scholar
  18. Blaivas JG, Labib KB, Michalik SJ, Zayed AAH (1980) Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications. J Urol 124: 259–262PubMedGoogle Scholar
  19. Blaschke TF, Melmon KL (1980) Antihypertensive agents and drug therapy of hypertension. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 793–818Google Scholar
  20. Bradley DV, Cazort RJ (1970) Relief of bladder spasm by flavoxate: a comparative study. J Clin Pharmacol 10: 65–68Google Scholar
  21. Briggs RS, Castleden CM, Asher MJ (1980) The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly. J Urol 123: 665–666PubMedGoogle Scholar
  22. Bultitude MI, Hills NH, Shuttleworth KED (1976) Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br J Urol 48: 631–637PubMedCrossRefGoogle Scholar
  23. Burgess CD, Turner P (1980) Cardiotoxicity of antidepressant drugs. Neuropharmacology 19: 1195–1199PubMedCrossRefGoogle Scholar
  24. Byck R (1975) Drugs and the treatment of psychiatric disorders. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 152–200Google Scholar
  25. Cameron MD (1966) Distigmine bromide (Ubretid) in the prevention of post-operative retention of urine. J Obstet Gynaecol Br Cwlth 73: 847–848CrossRefGoogle Scholar
  26. Cardozo DL, Stanton SL (1979) An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability. J Urol 122: 58–59PubMedGoogle Scholar
  27. Cardozo LD, Stanton SL (1980) A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol 123: 399–401PubMedGoogle Scholar
  28. Cardozo LD, Stanton SL, Robinson H, Hole D (1980) Evaluation of flurbiprofen in detrusor instability. Br Med J 280: 281–282PubMedCrossRefGoogle Scholar
  29. Castleden CM, George CF, Renwick AG, Asher MJ (1981) Imipramine - a possible alternative to current therapy for urinary incontinence in the elderly. J Urol 125: 318–320PubMedGoogle Scholar
  30. Chan WY, Dawood MY, Fuchs F (1981) Prostaglandins in primary dysmenorrhea. Am J Med 70: 535–541PubMedCrossRefGoogle Scholar
  31. Cole AT, Fried FA (1972) Favorable experiences with imipramine in the treatment of neurogenic bladder. J Urol 107: 44–45PubMedGoogle Scholar
  32. Council on Scientific Affairs, AMA (1982) Dimethyl sulfoxide. JAMA 248: 1369–1371CrossRefGoogle Scholar
  33. Crews FT, Smith CB (1978) Presynaptic alpha receptor subsensitivity after long-term antidepressant treatment. Science 202: 322–324PubMedCrossRefGoogle Scholar
  34. de Groat WC, Booth AM (1980) Physiology of the urinary bladder and urethra. Ann Int Med 92(2): 312–315Google Scholar
  35. de Groat WC, Saum WR (1972) Sympathetic inhibition of the urinary bladder and of pelvic ganglionic transmission in the cat. J Physiol (Lond) 220: 297–314Google Scholar
  36. de Groat WC, Saum WR (1976) Synaptic transmission in parasympathetic ganglia in the urinary bladder of the cat. J Physiol (Lond) 256: 137–158Google Scholar
  37. Delaere KPJ, Michiels HGE, Debruyne FMJ, Moonen WA (1977) Flavoxate hydrochloride in the treatment of detrusor instability. Urol Int 32: 377–381PubMedCrossRefGoogle Scholar
  38. Delaere KPJ, Thomas CME, Moonen W A, Debruyne FMJ (1981) The value of intravesical prostaglandin E2 and F in women with abnormalities of bladder emptying. Br J Urol 53: 306–309PubMedCrossRefGoogle Scholar
  39. Desmond AD, Bultitude MI, Hills NH, Shuttleworth KED (1980) Clinical experience with intravesical prostaglandin E2. A prospective study of 36 patients. Br J Urol 52: 357–366PubMedCrossRefGoogle Scholar
  40. Dhattiwala AS (1976) The effect of imipramine on isolated innervated guinea-pig and rat urinary bladder preparations. J Pharm Pharmacol 28: 453–454PubMedCrossRefGoogle Scholar
  41. Diokno AC, Koppenhoefer R (1976) Bethanechol chloride in neurogenic bladder dysfunction. Urology 8: 455–458PubMedCrossRefGoogle Scholar
  42. Diokno AC, Lapides J (1972) Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol 108: 307–309PubMedGoogle Scholar
  43. Diokno AC, Lapides J (1977) Action of oral and parenteral bethanechol on decompensated bladder. Urology 10: 23–24PubMedCrossRefGoogle Scholar
  44. Diokno AC, Taub M (1975) Ephedrine in treatment of urinary incontinence. Urology 5: 624–625PubMedCrossRefGoogle Scholar
  45. Diokno AC, Hyndman CW, Hardy DA, Lapides J (1972) Comparison of action of imipramine (Tofranil) and propantheline (Pro-Banthine) on detrusor contraction. J Urol 107: 42–43PubMedGoogle Scholar
  46. Donker PJ, Van der Sluis C (1976) Action of beta adrenergic blocking agents on the urethral pressure profile. Urol Int 31: 6–12PubMedCrossRefGoogle Scholar
  47. Downie JW, Twiddy DAS, Awad SA (1977) Antimuscarinic and noncompetitive antagonist properties of dicyclomine hydrochloride in isolated human and rabbit bladder muscle. J Pharmacol Exp Ther 201 : 662–668PubMedGoogle Scholar
  48. Duncan GW, Shahani BT, Young RR (1976) An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. Neurology 26: 441–446PubMedGoogle Scholar
  49. Ek A, Andersson K-E, Gullberg B, Ulmsten U (1978) The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile. Scand J Urol Nephrol 12: 105–110PubMedCrossRefGoogle Scholar
  50. Ekeland A, Sander S (1976) A urodynamic study of emepronium bromide in bladder dysfunction. Scand J Urol Nephrol 10: 195–199PubMedGoogle Scholar
  51. Ekman G, Andersson K-E, Rud T, Ulmsten U (1980) A double blind crossover study of the effects of terodiline in women with unstable bladder. Acta Pharmacol Toxicol 46 [Suppl] 1: 39–43Google Scholar
  52. Fingl E, Woodbury DM, (1975) General principles. In: Goodman L, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 1–46Google Scholar
  53. Finkbeiner AE, Welch LT, Bissada NK (1978) Uropharmacology. IX. Direct acting smooth muscle stimulants and depressants. Urology 12: 231–235PubMedCrossRefGoogle Scholar
  54. Fischer CP, Diokno A, Lapides J (1978) The anticholinergic effects of dicyclomine hydrochloride in uninhibited neurogenic bladder dysfunction. J Urol 120: 328–329PubMedGoogle Scholar
  55. Forman A, Andersson K-E, Henriksson L, Rud T, Ulmsten U (1978) Effects of nifedipine on the smooth muscle of the human urinary tract in-vitro and in-vivo. Acta Pharmacol Toxicol 43: 111–118CrossRefGoogle Scholar
  56. Fossberg E, Beisland HO, Sander S (1981) Sensory urgency in females: treatment with phenylpropanolamine. Eur Urol 7: 157–160PubMedGoogle Scholar
  57. Fowler JE Jr (1981) Prospective study of intravesical dimethyl sulfoxide in the treatment of suspected early interstitial cystitis. Urology 18: 21–26PubMedCrossRefGoogle Scholar
  58. Fox S, Krnjević K, Morris ME, Puil E, Werman R (1978) Action of baclofen on mammalian synaptic transmission. Neuroscience 3: 495–515PubMedCrossRefGoogle Scholar
  59. Franz DN (1975) Drugs for Parkinson’s disease: centrally acting muscle relaxants. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 227–244Google Scholar
  60. Fredericks CM, Green RL, Anderson GF (1978) Comparative in-vitro effects of imipramine, oxybutynin and flavoxate on rabbit detrusor. Urology 12: 487–491PubMedCrossRefGoogle Scholar
  61. Gibaldi M, Grundhofer B (1975) Biopharmaceutic influences on the anticholinergic effects of propantheline. Clin Pharmacol Ther 18: 457–461PubMedGoogle Scholar
  62. Gibbon NOK (1965) Urinary incontinence in disorders of the nervous system. Br J Urol 37: 624–632PubMedCrossRefGoogle Scholar
  63. Gleason DM, Reilly RJ, Bottaccini MR, PierceMJ (1974) The urethral continence zone and its relation to stress incontinence. J Urol 112: 81–88PubMedGoogle Scholar
  64. Gosling JA, Dixon JS, Critchley HOD, Thompson S-A (1981) A comparative study of the human external sphincter and periurethral levator ani muscles. Br J Urol 53: 35–41PubMedCrossRefGoogle Scholar
  65. Graham RM, Pettinger WA (1979) Prazosin. N Engl J Med 300: 232–236CrossRefGoogle Scholar
  66. Hachen HJ, Krocker V (1977) Clinical and laboratory assessment of the efficacy of baclofen on urethral sphincter spasticity in patients with traumatic paraplegia. Eur Urol 3: 237–240PubMedGoogle Scholar
  67. Hackler RH, Broecker BH, Klein FA, Brady SM (1980) A clinical experience with dantrolene sodium for external urinary sphincter hypertonicity in spinal cord injured patients. J Urol 124: 78–81PubMedGoogle Scholar
  68. Harris JD, Benson GS (1980) Effect of dantrolene sodium on canine bladder contractility. Urology 16: 229–231PubMedCrossRefGoogle Scholar
  69. Hartviksen K (1966) Discussion. Acta Neurol Scand 42 [Suppl] 20: 180Google Scholar
  70. Hebjørn S, Walter S (1978) Treatment of female incontinence with emepronium bromide. Urologia Int 33: 120–129CrossRefGoogle Scholar
  71. Hebjørn S (1977) Treatment of detrusor hyperreflexia in multiple sclerosis. Urol Int 32: 209–217PubMedCrossRefGoogle Scholar
  72. Hebjørn S, Andersen JT, Walter S, Dam AM (1976) Detrusor hyperreflexia. Scand J Urol Nephrol 10: 103–109PubMedCrossRefGoogle Scholar
  73. Hilton P, Stanton SL (1982) The use of desmopressin (DDA VP) in nocturnal urinary frequency in the female. Br J Urol 54: 252–255PubMedCrossRefGoogle Scholar
  74. Hinman F (1974) Urinary tract damage in children who wet. Pediatrics 54: 142–150Google Scholar
  75. Hinman F Jn (1980) Syndromes of vesical incoordination. Urol Clin N Am 7: 311–319Google Scholar
  76. Hodgson BJ, Dumas S, Bolling DR, Heesch CM (1978) Effect of estrogen on sensitivity of rabbit bladder and urethra to phenylephrine. Invest Urol 16: 67–69PubMedGoogle Scholar
  77. Hollister LE (1978) Tricyclic antidepressants. N Engl J Med 299: 1106–1109PubMedCrossRefGoogle Scholar
  78. Holmberg E, Waldeck B (1980) On the possible role of potassium ions in the action of terbutaline on skeletal muscle contractions. Acta Pharmacol Toxicol 46: 141–149CrossRefGoogle Scholar
  79. Husted S, Andersson K-E, Sommer L, Østergaard JR (1980) Anticholinergic and calcium antagonistic effects of terodiline in rabbit urinary bladder. Acta Pharmacol Toxicol 46 [Suppl] 1: 20–30CrossRefGoogle Scholar
  80. Innes IR, Nickerson M (1975) Atropine, scopolamine, and related antimuscarinic drugs. In: Goodman L, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 514–532Google Scholar
  81. Jensen D Jr (1981) Pharmacological studies of the uninhibited neurogenic bladder. Acta Neurol Scand 64: 175–195PubMedCrossRefGoogle Scholar
  82. Johns A, Tasker JJ, Johnson CE, Theman MA, Paton DM (1976) The mechanism of action of dicyclomine hydrochloride on rabbit detrusor muscle and vas deferens. Arch Int Pharmacodyn 224: 109–113PubMedGoogle Scholar
  83. Johnston JH, Farkas A (1975) Congenital neuropathic bladder: practicalities and possibilities of conservational management. Urology 5: 719–727PubMedCrossRefGoogle Scholar
  84. Jonas D, Linzbach P, Weber W (1979a) The use of midodrin in the treatment of ejaculation disorders following retroperitoneal lymphadenectomy. Eur Urol 5: 184–187PubMedGoogle Scholar
  85. Jonas U, Petri E, Kissal J (1979b) The effect of flavoxate on hyperactive detrusor muscle. Eur Urol 5: 106–108PubMedGoogle Scholar
  86. Jones RF, Burke D, Marosszeky JE, Gillies JD (1970) A new agent for the control of spasticity. J Neurol Neurosurg Psychiatry 33: 464–468PubMedCrossRefGoogle Scholar
  87. Kaneko S, Minami K, Yachiku S, Kurita T (1980) Bladder neck dysfunction. The effect of the alpha adrenergic blocking agent phentolamine on bladder neck dysfunction and a fluorescent histochemical study of bladder neck smooth muscle. Invest Urol 18: 212–218PubMedGoogle Scholar
  88. Kedia KR, Persky L (1981) Effect of phenoxybenzamine (Dibenzyline) on sexual function in man. Urology 18: 620–622PubMedCrossRefGoogle Scholar
  89. Khanna OP (1976) Disorders of micturition: neuropharmacologic basis and results of drug therapy. Urology 8: 316–328PubMedCrossRefGoogle Scholar
  90. Khanna OP, DiGregorio GJ, Barbieri EJ, McMichael RF, Ruch E (1979) In-vitro study of antispasmodic effects of dicyclomine hydrochloride on vesicourethral smooth muscle of guinea pig and rabbit. Urology 13: 457–462PubMedCrossRefGoogle Scholar
  91. Khanila OP, Barbieri EJ, McMichael RF (1981) The effects of adrenergic agonists and antagonists on vesicourethral smooth muscle of rabbit. J Pharmacol Exp Ther 216: 95–100Google Scholar
  92. Kiesswetter H, Hennrich F, Englisch M (1983) Clinical and urodynamic assessment of pharmacologic therapy of stress incontinence. Urol Int 38: 58–63PubMedCrossRefGoogle Scholar
  93. Kilbinger H, Weihrauch TR (1982) Drugs increasing gastrointestinal motility. Pharmacology 25: 61–72PubMedCrossRefGoogle Scholar
  94. Kleeman FJ (1970) The physiology of the internal urinary sphincter. J Urol 104: 549–554PubMedGoogle Scholar
  95. Koelle GB (1975) Parasympathomimetic agents. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 467–476Google Scholar
  96. Kohler FP, Morales PA (1968) Cystometric evaluation of flavoxate hydrochloride in normal and neurogenic bladders. J Urol 100: 729–730PubMedGoogle Scholar
  97. Korczyn AD, Kish I (1979) The mechanism of imipramine in enuresis nocturna. Clin Exp Pharmacol Physiol 6: 31–35PubMedCrossRefGoogle Scholar
  98. Kosman ME (1978) Evaluation of a new antidiuretic agent, desmopressin acetate (DDA VP). JAMA 240: 1896–1897PubMedCrossRefGoogle Scholar
  99. Krane RJ, Olsson CA (1973a) Phenoxybenzamine in neurogenic bladder dysfunction. I. A theory of micturition. J Urol 110: 650–652PubMedGoogle Scholar
  100. Krane RJ, Olsson CA (1973b) Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations. J Urol 110: 653–656PubMedGoogle Scholar
  101. Krier J, Thor KB, De Groat WC (1979) Effects of clonidine on the lumbar sympathetic pathways to the large intestine and urinary bladder of the cat. Eur J Pharmacol 59: 47–53PubMedCrossRefGoogle Scholar
  102. Kunin SA, Limbert DJ, Platzker ACG, McGinley J (1970) The efficacy of imipramine in the management of enuresis. J Urol 104: 612–615PubMedGoogle Scholar
  103. Lapides J (1964) Urecholine regimen for rehabilitating the atonic bladder. J Urol 91: 658–659PubMedGoogle Scholar
  104. Lapides J (1974) Neurogenic bladder: principles of treatment. Urol Clin N Am 1: 81–97Google Scholar
  105. Lapides J, Dodson A Jr (1953) Observations on effect of methantheline bromide in urological disturbances. Arch Surg 66: 1–9Google Scholar
  106. Lapides J, Friend CR, Ajemian EP, Sonda LP (1963) Comparison of action of oral and parenteral bethanechol chloride upon the urinary bladder. Invest Urol 1: 94–97PubMedGoogle Scholar
  107. Larsen J-J, Mortensen S (1978) Effect of ritodrine on the bladder capacity in unanaesthetized pigs. Acta Pharmacol Toxicol 43: 405–408CrossRefGoogle Scholar
  108. Lee LW (1949) The clinical use of urecholine in dysfunctions of the bladder. J Urol 62: 300–307PubMedGoogle Scholar
  109. Levin RM, Shofer FS, Wein AJ (1980) Cholinergic, adrenergic and purinergic response of sequential strips of rabbit urinary bladder. J Pharmacol Exp Ther 212: 536–540PubMedGoogle Scholar
  110. Levin RM, Jacobowitz D, Wein AJ (1981) Autonomic innervation of rabbit urinary bladder following estrogen administration. Urology 17: 449–453PubMedCrossRefGoogle Scholar
  111. Levin RM, Staskin D, Wein AJ (1982) The muscarinic cholinergic binding kinetics of the human urinary bladder. Neurol Urodynamics 1: 221–225CrossRefGoogle Scholar
  112. Leyson FJ, Martin BF, Sporer A (1980) Baclofen in the treatment of detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 124: 82–84PubMedGoogle Scholar
  113. Lish PM, Labudde JA, Peters EL, Robbins SI (1965) Oxybutynin: a musculotropic antispasmodic drug with moderate anticholinergic action. Arch Int Pharmacodyn 156: 467–488PubMedGoogle Scholar
  114. MacGregor RJ, Diokno AC (1981) The alpha adrenergic blocking action of prazosin hydrochloride on the canine urethra. Invest Urol 18: 426–429PubMedGoogle Scholar
  115. McGuire E (1979) Urethral sphincter mechanisms. Urol Clin N Am 6: 39–49Google Scholar
  116. McGuire EJ, Lytton B, Pepe V, Kohorn EI (1976) Stress urinary incontinence. Obstet Gynecol 47: 255–264PubMedGoogle Scholar
  117. McNally C (1982) Smith-Kline Company. Personal communication (letter)Google Scholar
  118. Mahony DT, Laferte RO, Mahoney JE (1973) Observations on sphincter augmenting effect of imipramine in children with urinary incontinence. Urology 1: 317–323PubMedCrossRefGoogle Scholar
  119. Månsson W, Sundin T, Gullberg B (1980) Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. Scand J Urol Nephrol 14: 139–141PubMedCrossRefGoogle Scholar
  120. Medical Letter (1980) Dimethyl sulfoxide (DMSO). Med Lett 22: 94–95Google Scholar
  121. Merrill DC, Rotta J (1974) A clinical evaluation of detrusor denervation supersensitivity using air cystometry. J Urol 111: 27–30PubMedGoogle Scholar
  122. Meyhoff HH, Nordling J (1981) Different cystometric types of deficient micturition reflex control in female urinary incontinence with special reference to the effect of parasympatholytic treatment. Br J Urol 53: 129–133PubMedCrossRefGoogle Scholar
  123. Milner G, Hills NF (1968) A double-blind assessment of antidepressants in the treatment of 212 enuretic patients. Med J Aust I: 943–947Google Scholar
  124. Mirakhur R, Dundee J (1980) Comparison of the effects of atropine and glycopyrrolate on various end organs. J R Soc Med 73: 727–730PubMedGoogle Scholar
  125. Mirakhur RK, Dundee JW, Jones CJ (1978) Evaluation of the anticholinergic actions of glycopyrronium bromide. Br J Clin PharmacoI5: 77–81Google Scholar
  126. Moisey CU, Stephenson TP, Brendler CB (1980) The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Br J Urol 52: 472–475PubMedCrossRefGoogle Scholar
  127. Moncada S, Flower R, Vane J (1980) Prostaglandins, prostacyclin, and thromboxane A2. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 668–681Google Scholar
  128. Montague DK, Stewart BH (1979) Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence. J Urol 122: 198–199PubMedGoogle Scholar
  129. Muller J, Schulze S (1980) Imipramine cardiotoxicity: an electrocardiographic and hemodynamic study in rabbits. Acta Pharmacol Toxicol 46: 191–199CrossRefGoogle Scholar
  130. Murdock MM, Sax D, Krane RJ (1976) Use of dantrolene sodium in external sphincter spasm. Urology 8: 133–137PubMedCrossRefGoogle Scholar
  131. Nanninga JB, Kaplan P, Lal S (1977) Effect of phentolamine on perineal muscle EMG activity in paraplegia. Br J Urol 49: 537–539PubMedCrossRefGoogle Scholar
  132. Noack CH (1964) Enuresis nocturna: a long-term study of 44 children treated with imipramine hydrochloride (Tofranil) and other drugs. Med J Aust I: 191–194Google Scholar
  133. Nordling J, Meyhoff HH, Christensen NJ (1979) Effects of clonidine (Catapresan) on urethral pressure. Invest Urol 16: 289–291PubMedGoogle Scholar
  134. Norlén L, Sundin T, Waagstein F (1978) Beta-adrenoceptor stimulation of the human urinary bladder in-vivo. Acta Pharmacol Toxicol 43 [Suppl II]: 26–30CrossRefGoogle Scholar
  135. Öbrink A, Bunne G (1978) The effect of alpha adrenergic stimulation in stress incontinence. Scand J Urol Nephrol 12: 205–208PubMedCrossRefGoogle Scholar
  136. Olsson CA, Siroky MB, Krane RJ (1977) The phentolamine test in neurogenic bladder dysfunction. J Urol 117: 481–485PubMedGoogle Scholar
  137. Olsson OAT, Swanberg E, Svedinger I, Waldeck B (1979) Effects of p-adrenoceptor agonists on airway smooth muscle and on slow-contracting skeletal muscle: in-vitro and in-vivo results compared. Acta Pharmacol Toxicol 44: 272–276CrossRefGoogle Scholar
  138. Olubadewo JO (1980) The effect of imipramine on rat detrusor muscle contractility. Arch Int Pharmacodyn 245: 84–94PubMedGoogle Scholar
  139. Palmer JH, Worth PH, Exton-Smith AN (1981) Flunarizine: a once daily therapy for urinary incontinence. Lancet III: 279–281CrossRefGoogle Scholar
  140. Paulson DF (1978) Oxybutynin chloride in control of post-transurethral vesical pain and spasm. Urology 11: 237–238PubMedCrossRefGoogle Scholar
  141. Pederson E, Grynderup V (1966) Clinical pharmacology of the neurogenic bladder. Acta Neurol Scand (Suppl) 42: 111CrossRefGoogle Scholar
  142. Perera GLS, Ritch AES, Hall MRP (1982) The lack of effect of intramuscular emepronium bromide for urinary incontinence. Br J Urol 54: 259–260PubMedCrossRefGoogle Scholar
  143. Perlberg S, Caine M (1982) Adrenergic response of bladder muscle in prostatic obstruction. Urology 20: 524–527PubMedCrossRefGoogle Scholar
  144. Petersen KE, Andersen OO, Hansen T (1974) Mode of action and relative value of imipramine and similar drugs in the treatment of nocturnal enuresis. Eur J Clin Pharmacol 7: 187–194PubMedCrossRefGoogle Scholar
  145. Petti TA, Law W (1981) Abrupt cessation of high dose imipramine therapy treatment in children. JAMA 246: 768–769PubMedCrossRefGoogle Scholar
  146. Philp NH, Thomas DG (1980) The effect of distigmine bromide on voiding in male paraplegic patients with reflex micturition. Br J Urol 52: 492–496PubMedCrossRefGoogle Scholar
  147. Philp NH, Thomas DG, Clarke SJ (1980) Drug effects on the voiding cystometrogram: a comparison of oral bethanechol and carbachol. Br J Urol 52: 484–487PubMedCrossRefGoogle Scholar
  148. Raezer DM, Wein AJ, Jacobowitz D, Corriere IN Jr (1973) Autonomic innervation of canine urinary bladder: cholinergic and adrenergic contributions and interaction of sympathetic and parasympathetic nervous systems in bladder function. Urology 2: 211–221CrossRefGoogle Scholar
  149. Raezer DM, Benson GS, Wein AJ, Duckett JW Jr (1977) The functional approach to the management of the pediatric neuropathic bladder. A clinical study. J Urol 117: 649–654PubMedGoogle Scholar
  150. Ramsden PD, Hindmarsh JR, Price DA, Yeates WK, Bowditch JDP (1982) DDAVP for adult enuresis - a preliminary report. Br J Urol 54: 256–258PubMedCrossRefGoogle Scholar
  151. Rashbaum M, Mandelbaum CC (1948) Non-operative treatment of urinary incontinence in women. Am J Obstet Gynecol 56: 777–780PubMedGoogle Scholar
  152. Raz S, Caine M (1972) Adrenergic receptors in the female canine urethra. Invest Urol 9: 319–323PubMedGoogle Scholar
  153. Raz S, Smith RB (1976) External sphincter spasticity syndrome in female patients. J Urol 115: 443–446PubMedGoogle Scholar
  154. Raz S, Zeigler M, Caine (1973) The role of female hormones in stress incontinence. In: Proceedings of the 16th Congress of the Societe International d’Urologie, Amsterdam, vol 2. Doin, Paris, pp 397–402Google Scholar
  155. Raz S, Kaufman JJ, Ellison GW, Mayers LW (1977) Methyldopa in treatment of neurogenic bladder disorders. Urology 9: 188–190PubMedCrossRefGoogle Scholar
  156. Rees DLP, Ransley PG (1980) Eskornade in the treatment of diurnal incontinence in children. Br J Urol 52: 476–479PubMedCrossRefGoogle Scholar
  157. Rees DLP, Whitfield HN, Islam AKMS, Doyle PT, Mayo ME, Wickham JEA (1976) Urodynamic findings in adult females with frequency and dysuria. Br J Urol 47: 853–860CrossRefGoogle Scholar
  158. Richelson E (1983) Antimuscarinic and other receptor blocking properties of antidepressants. Mayo Clin Proc 58: 40–46PubMedGoogle Scholar
  159. Richter JE, Castell DO (1982) Gastroesophageal reflux. Ann Int Med 97: 93–103PubMedGoogle Scholar
  160. Ritch AES, George CF, Castleden CM, Hall MRP (1977) A second look at emepronium bromide in urinary incontinence. Lancet 1: 504–506PubMedCrossRefGoogle Scholar
  161. Robinson AG (1976) DDA VP in the treatment of central diabetes insipidus. N Engl J Med 294: 507–511PubMedCrossRefGoogle Scholar
  162. Rohner TJ, Hannigan JD, Sanford EJ (1978) Altered in-vitro adrenergic responses of dog detrusor muscle after chronic bladder outlet obstruction. Urology 11: 357–361PubMedCrossRefGoogle Scholar
  163. Ron M, Shapiro A, Caine M (1980) The action of bromocriptine on human detrusor muscle. Urol Res 8: 207–209PubMedCrossRefGoogle Scholar
  164. Rosenbaum AH, Maruta T, Richelson E (1979) Drugs that alter mood. Tricyclic agents and monoamine oxidase inhibitors. Mayo Clin Proc 54: 335–344PubMedGoogle Scholar
  165. Rossier AB, Fam BA, Lee IY, Sarkarati M, Evans DA (1982) Role of striated and smooth muscle components in the urethral pressure profile in traumatic neurogenic bladders: a neuropharmacological and urodynamic study. Preliminary report. J Urol 128: 529–535PubMedGoogle Scholar
  166. Roussan MS, Abramson AS, Levine SA, Feibel A (1975) Bladder training: its role in evaluating the effect of an antispasticity drug on voiding in patients with neurogenic bladder. Arch Phys Med Rehabil 56: 463–468PubMedGoogle Scholar
  167. Rud T (1980a) The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynecol Scand 59: 265–270PubMedCrossRefGoogle Scholar
  168. Rud T (1980b) Urethral pressure profile in continent women from childhood to old age. Acta Obstet Gynecol Scand 59: 331–335PubMedCrossRefGoogle Scholar
  169. Rud T, Andersson K-E, Boye N, Ulmsten U (1980) Terodiline inhibition of human bladder contraction. Effects in vitro and in women with unstable bladder. Acta Pharmacol Toxicol 46 [Suppl] 1: 31–38CrossRefGoogle Scholar
  170. Salmon UJ, Walter RI, Geist SH (1941) The use of estrogen in the treatment of dysuria and incontinence in post-menopausal women. Am J Obstet Gynecol 42: 845–851Google Scholar
  171. Schreiter F, Fuchs P, Stockamp K (1976) Estrogenic sensitivity of alpha receptors in the urethral musculature. Urol Int 31: 13–19PubMedCrossRefGoogle Scholar
  172. Sjögren C, Andersson K-E (1979) Effects of cholinoceptor blocking drugs, adrenoceptor stimulants and calcium antagonists on the transmurally stimulated guinea pig urinary bladder in-vitro and in-vivo. Acta Pharmacol Toxicol 44: 228–234CrossRefGoogle Scholar
  173. Smey P, King LR, Firlit CF (1980) Dysfunctional voiding in children secondary to internal sphincter dyssynergia: treatment with phenoxybenzamine. Urologic Clin N Am 7: 337–347Google Scholar
  174. Sonda LP, Gershon C, Diokno AC, Lapides J (1979) Further observations on the cystometric and uroflowmetric effects of bethanechol chloride on the human bladder. J Urol 122: 775–777PubMedGoogle Scholar
  175. Sporer A, Leyson JFJ, Martin BF (1978) Effects of bethanechol chloride on the external urethral sphincter in spinal cord injury patients. J Urol 120: 62–66PubMedGoogle Scholar
  176. Spyraki C, Fibiger HC (1980) Functional evidence for subsensitivity of noradrenergic α-2 receptors after chronic desipramine treatment. Life Sci 27: 1863–1867PubMedCrossRefGoogle Scholar
  177. Stanton SL (1973) A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence. J Urol 110: 529–532PubMedGoogle Scholar
  178. Stanton SL (1978) Diseases of the urinary system. Drugs acting on the bladder and urethra. Br Med J 1: 1607–1608PubMedCrossRefGoogle Scholar
  179. Starr I, Ferguson LK (1940) Beta methylcholine urethane. Its action in various normal and abnormal conditions, especially postoperative urinary retention. Am J Med Sci 200: 372–385CrossRefGoogle Scholar
  180. Stewart BH, Shirley SW (1976) Further experience with intravesical DMSO in the treatment of interstitial cystitis. J Urol 116: 36–38PubMedGoogle Scholar
  181. Stewart BH, Banowsky LHW, Montague DK (1976) Stress incontinence: conservative therapy with sympathomimetic drugs. J Urol 115: 558–559PubMedGoogle Scholar
  182. Stockamp K (1975) Treatment with phenoxybenzamine of upper urinary tract complications caused by intravesical obstruction. J Urol 113: 128–131PubMedGoogle Scholar
  183. Stockamp K, Schreiter F (1975) Alpha adrenolytic treatment of the congenital neuropathic bladder. Urol Int 30: 33PubMedCrossRefGoogle Scholar
  184. Tulloch AGS, Creed KE (1979) A comparison between propantheline and imipramine on bladder and salivary gland function. Br J Urol 51: 359–362PubMedCrossRefGoogle Scholar
  185. Turner-Warwick R (1979) A urodynamic review of bladder outlet obstruction in the male and its clinical implications. Urol Clin N Am 6: 171–192Google Scholar
  186. Turner-Warwick R, Whiteside CG, Worth PHL, Milroy EJG, Bates CP (1973) A urodynamic view of the clinical problems associated with bladder neck dysfunction and its treatment by endoscopic incision and transtrigonal posterior prostatectomy. Br J Urol 45: 44–59PubMedGoogle Scholar
  187. Ulmsten U, Andersson K-E, Persson CGA (1977) Diagnostic and therapeutic aspects of urge urinary incontinence in women. Urol Int 32: 88–96PubMedCrossRefGoogle Scholar
  188. Ursillo RC (1967) Rationale for drug therapy in bladder dysfunction. In: Boyarsky S (ed) The neurogenic bladder. Williams & Wilkins, Baltimore, pp 187–190Google Scholar
  189. Vaidyanathan S, Rao MS, Bapna BC, Chary KSN, Palaniswamy R (1980) Beta adrenergic activity in human proximal urethra: a study with terbutaline. J Urol 124: 869–871PubMedGoogle Scholar
  190. Veith RC, Raskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306: 954–959PubMedCrossRefGoogle Scholar
  191. Walter S, Hansen J, Hansen L, Maegaard E, Meyhoff HH, Nordling J (1982) Urinary incontinence in old age. A controlled clinical trial of emepronium bromide. Br J Urol 54: 249–251PubMedCrossRefGoogle Scholar
  192. Wein AJ (1979) Pharmacologic approaches to the management of neurogenic bladder dysfunction. Journal of Continuing Education in Urology 18(5): 17–34Google Scholar
  193. Wein AJ (1980) Pharmacology of the bladder and urethra. In: Stanton SL, Tanagho EA (eds) Surgery of female incontinence. Springer-Verlag, Berlin Heidelberg New York, pp 185–199Google Scholar
  194. Wein AJ (1981) Classification of neurogenic voiding dysfunction. J Urol 125: 605–609PubMedGoogle Scholar
  195. Wein AJ, Raezer DM (1979) Physiology of micturition. In: Krane R, Siroky M (eds) Clinical neurology. Little, Brown & Co., Boston, pp 1–33Google Scholar
  196. Wein AJ, Hanno PM, Dixon DO, Raezer DM, Benson GS (1978) The effect of oral bethanechol chloride on the cystometrogram of the normal adult male. J Urol 120: 330–331PubMedGoogle Scholar
  197. Wein AJ, Benson GS, Jacobowitz D (1979) Lack of evidence for adrenergic innervation of the external urethral sphincter. J Urol 121: 324–326PubMedGoogle Scholar
  198. Wein AJ, Raezer DM, Malloy TR (1980a) Failure of the bethanechol supersensitivity test to predict improved voiding after subcutaneous bethanechol administration. J Urol 123: 202–203PubMedGoogle Scholar
  199. Wein AJ, Malloy TR, Shofer F, Raezer DM (1980b) The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes. J Urol 124: 397–399PubMedGoogle Scholar
  200. Weiner N (1980a) Atropine, scopolamine and related antimuscarinic drugs. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 120–137Google Scholar
  201. Weiner N (1980b) Norepinephrine, epinephrine and the sympathomimetic amines. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 138–175Google Scholar
  202. Weiner N (1980c) Drugs that inhibit adrenergic nerves and block adrenergic receptors. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 176–210Google Scholar
  203. Weinshilboum RM (1980) Antihypertensive drugs that alter adrenergic function. Mayo Clin Proc 55: 390–402PubMedGoogle Scholar
  204. Whitfield HN, Doyle PT, Mayo ME, Poopalasingham N (1976) The effect of adrenergic blocking drugs on outflow resistance. Br J Urol 47: 823–827CrossRefGoogle Scholar
  205. Woodhead DM, Hall TC, Snodgrass WT (1967) An effective control of benign enuresis. J Urol 97: 98–100PubMedGoogle Scholar
  206. Yalla SV, Blunt KJ, Fam BA, Constantinople NL, Gittes RF (1977) Detrusor-urethral sphincter dyssynergia. J Urol 118: 1026–1029PubMedGoogle Scholar
  207. Ziegler MG, Lake CR, Williams AC, Teychenne PF, Shoulson I, Steinsland O (1979) Bromocriptine inhibits norepinephrine release. Clin Pharmacol Ther 25: 137–142PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Alan J. Wein

There are no affiliations available

Personalised recommendations